1. Home
  2. AVDL vs NIC Comparison

AVDL vs NIC Comparison

Compare AVDL & NIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • NIC
  • Stock Information
  • Founded
  • AVDL 2015
  • NIC 2000
  • Country
  • AVDL Ireland
  • NIC United States
  • Employees
  • AVDL N/A
  • NIC N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • NIC Major Banks
  • Sector
  • AVDL Health Care
  • NIC Finance
  • Exchange
  • AVDL Nasdaq
  • NIC Nasdaq
  • Market Cap
  • AVDL 1.4B
  • NIC 1.7B
  • IPO Year
  • AVDL 1996
  • NIC N/A
  • Fundamental
  • Price
  • AVDL $11.66
  • NIC $112.83
  • Analyst Decision
  • AVDL Strong Buy
  • NIC Hold
  • Analyst Count
  • AVDL 6
  • NIC 5
  • Target Price
  • AVDL $24.00
  • NIC $101.60
  • AVG Volume (30 Days)
  • AVDL 1.7M
  • NIC 65.9K
  • Earning Date
  • AVDL 11-12-2024
  • NIC 01-14-2025
  • Dividend Yield
  • AVDL N/A
  • NIC 0.99%
  • EPS Growth
  • AVDL N/A
  • NIC 102.58
  • EPS
  • AVDL N/A
  • NIC 7.86
  • Revenue
  • AVDL $138,160,000.00
  • NIC $342,790,000.00
  • Revenue This Year
  • AVDL $533.23
  • NIC N/A
  • Revenue Next Year
  • AVDL $73.08
  • NIC $4.63
  • P/E Ratio
  • AVDL N/A
  • NIC $14.35
  • Revenue Growth
  • AVDL 1523.50
  • NIC 28.93
  • 52 Week Low
  • AVDL $10.41
  • NIC $72.70
  • 52 Week High
  • AVDL $19.09
  • NIC $116.17
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 40.12
  • NIC 62.75
  • Support Level
  • AVDL $10.41
  • NIC $108.52
  • Resistance Level
  • AVDL $16.66
  • NIC $116.17
  • Average True Range (ATR)
  • AVDL 0.88
  • NIC 3.23
  • MACD
  • AVDL -0.31
  • NIC -0.22
  • Stochastic Oscillator
  • AVDL 20.00
  • NIC 78.16

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

Share on Social Networks: